5 Idea Friday: capex, slow n' steady (and others)

The surprisingly linear ascent of tech capex, mysteries of biotech capital allocation, ex-chinese etailers, never go full French, and CRE's bottom (and the niche that could)

• tech capex, less cyclical?

• Random Walk ponders capital allocation in biotech (and some weirdness)

• China levels the playing field for US etailers(?)

• Never go Full French (pension)

• CRE’s bottom, and the little niche that could